{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:52:20Z","timestamp":1768031540838,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.025","type":"journal-article","created":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T07:16:20Z","timestamp":1595747780000},"page":"e361-e364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case series"],"prefix":"10.1016","volume":"60","author":[{"suffix":"Jr","given":"Francisco","family":"Ibarra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallory","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.japh.2020.06.025_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WOX.0b013e31817aecbe","article-title":"Angioedema","volume":"1","author":"Kaplan","year":"2008","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.japh.2020.06.025_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40521-019-0203-y","article-title":"Current treatment of angioedema induced by ACE inhibitors","volume":"6","author":"Terreehorst","year":"2019","journal-title":"Curr Treat Options Allergy"},{"issue":"2","key":"10.1016\/j.japh.2020.06.025_bib3","first-page":"92","article-title":"Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway","volume":"2014","author":"Tharayil","year":"2014","journal-title":"Qatar Med J"},{"issue":"2","key":"10.1016\/j.japh.2020.06.025_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ccr3.171","article-title":"Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert\u00ae): about one case and review of the therapeutic arsenal","volume":"3","author":"Lipski","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.japh.2020.06.025_bib5","first-page":"3930923","article-title":"The use of plasma-derived complement C1-esterase inhibitor concentrate (Berinert\u00ae) in the treatment of angiotensin converting enzyme-inhibitor related angioedema","volume":"2016","author":"Hermanrud","year":"2016","journal-title":"Case Rep Emerg Med"},{"issue":"4","key":"10.1016\/j.japh.2020.06.025_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2007.09.024","article-title":"The spectrum and treatment of angioedema","volume":"121","author":"Temi\u00f1o","year":"2008","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.japh.2020.06.025_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11882-011-0238-z","article-title":"ACE inhibitor\u2013induced angioedema","volume":"12","author":"Vasekar","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.japh.2020.06.025_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein","year":"2017","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.japh.2020.06.025_bib9","doi-asserted-by":"crossref","first-page":"26438","DOI":"10.1155\/2007\/26438","article-title":"Angioedema: clinical and etiological aspects","volume":"2007","author":"Kulthanan","year":"2007","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.japh.2020.06.025_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.18176\/jiaci.0058","article-title":"Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media","volume":"26","author":"Rosado Ingelmo","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.japh.2020.06.025_bib11","series-title":"(C1 Esterase Inhibitor) [Package Insert]","first-page":"04","year":"2019"},{"key":"10.1016\/j.japh.2020.06.025_bib12","series-title":"(Ecallantide) [Package Insert]","first-page":"09","year":"2014"},{"key":"10.1016\/j.japh.2020.06.025_bib13","series-title":"(Icatibant) [Package Insert]","first-page":"12","year":"2015"},{"key":"10.1016\/j.japh.2020.06.025_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006849","article-title":"Fresh frozen plasma in the treatment of ACE inhibitor-induced angioedema","volume":"2012","author":"Stewart","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.japh.2020.06.025_bib15","series-title":"Active Ingredient: C1 Esterase Inhibitor, Human. RED BOOK Online. Micromedex","year":"2020"},{"issue":"3","key":"10.1016\/j.japh.2020.06.025_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2500\/ar.2016.7.0166","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated angioedema treated with c1-esterase inhibitor: a case report and review of the literature","volume":"7","author":"Erickson","year":"2016","journal-title":"Allergy Rhinol (Providence)"},{"issue":"1","key":"10.1016\/j.japh.2020.06.025_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-6576.2005.00819.x","article-title":"Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate","volume":"50","author":"Nielsen","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"10.1016\/j.japh.2020.06.025_bib18","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.jemermed.2015.06.076","article-title":"Use of C1 inhibitor for angiotensin-converting enzyme (ACE) inhibitor-induced angioedema decreases mechanical ventilation time","volume":"49","author":"Urnoski","year":"2015","journal-title":"J\u00a0Emerg Med"},{"issue":"6","key":"10.1016\/j.japh.2020.06.025_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0897190016677427","article-title":"CI Esterase inhibitor (Berinert) for ACE inhibitor-induced angioedema: two case reports","volume":"30","author":"Leibfried","year":"2017","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.japh.2020.06.025_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200652","article-title":"ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate","volume":"2013","author":"Rasmussen","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.japh.2020.06.025_bib21","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1002\/lary.25113","article-title":"Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema","volume":"125","author":"Greve","year":"2015","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.japh.2020.06.025_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1067\/mai.2002.121313","article-title":"Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema","volume":"109","author":"Karim","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.japh.2020.06.025_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1081-1206(10)61766-8","article-title":"Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema","volume":"92","author":"Warrier","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.japh.2020.06.025_bib24","doi-asserted-by":"crossref","first-page":"192.e1","DOI":"10.1016\/j.ajem.2016.06.089","article-title":"Angiotensin-converting enzyme inhibitor\u2013induced angioedema worsened with fresh frozen plasma","volume":"35","author":"Adebayo","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.japh.2020.06.025_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jemermed.2007.02.024","article-title":"Effective treatment of hereditary angioedema with fresh frozen plasma in an emergency department","volume":"33","author":"Pekdemir","year":"2007","journal-title":"J\u00a0Emerg Med"},{"issue":"4","key":"10.1016\/j.japh.2020.06.025_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.japh.2020.06.025_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor\u2013induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.japh.2020.06.025_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.japh.2020.06.025_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A\u00a0randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120303150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120303150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:49Z","timestamp":1761544129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120303150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120303150"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.025","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case series","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}